Na mate na Alzheimer e dua na mate ni mona e vakavuna na kena vuca na sela ni mona, lai vakavuna tale ga na kena sega ni cakacaka vinaka na vakasama.
E vakavuna vakalevu na mate ni vakasama, e rauta ni 60-80% na kena mate.
E dau tini ena mate na mate oqo, ni rawa ni bula tiko me 4 ina 8 na yabaki e dua ni sa tauvi koya, ia e so era rawa ni bula tiko me 20 na yabaki.
E duidui na iwiliwili ni mate e vu mai na mate na Alzheimer's disease, e vakatau ena vakadidike kei na kedra iwiliwili na lewenivanua.
E kaya na Alzheimer's Association, ni mate oqo e ikaono ni mate e vakavuna vakalevu na mate e Mereke, e ikalima tale ga ni mate vei ira na yabaki 65 se sivia.
Ena 2019, na mate ni Alzheimer e tukuni ni vakavuna na mate vei ira e 121,9444 na tamata e Amerika.
E bibi me nanumi ni mate e vakavuna na Alzheimer's e sega ni vu ga mai na mate, e vu tale ga mai na mate e vakavuna na mate e tauvi koya kei na so tale na mate e dau vakavuna.
Ni sa toso tiko na mate, ena dredre vei ira na tauvimate mera cakava na ka era dau cakava e veisiga, me vaka na kana, sili, kei na isulu, qori e rawa ni vakavuna na kanavakaca, tauvimate, kei na so tale na leqa.
Kena ikuri, o ira na tauvi Alzheimer era rawa ni lutu, ni tauvi ira na niumonia, kei na so tale na mate.
E sega ni dua na iwali ni mate oqo, ia e tiko na kena iwali e rawa ni vukei iko mo lewa vinaka na kena ivakatakilakila, me vinaka tale ga na ivakarau ni nomu bula.
E se caka tiko ga na vakadidike me kunei kina na iwali ni mate rerevaki oqo.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.
Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.
Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.
Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.
['iVakamacala: veiqaravi vakavuniwai']
['Na website qo e vakarautaki me baleta ga na vuli kei na itukutuku, e sega ni kena inaki me soli kina na ivakasala vakavuniwai se veiqaravi vakavuniwai.']
['Na itukutuku e vakarautaki e sega ni dodonu me vakayagataki me dikevi kina se me qaravi kina e dua na mate, o ira tale ga na via qara ivakasala vakavuniwai mera lai raici vuniwai.']
['Me nanumi tiko ni neural network e dau vakarautaka na isaunitaro e sega ni dau donu ena gauna e cakacakataki kina na iwiliwili, me vaka na kedra iwiliwili na tauvimate.']
['Ke o nanuma ni o tauvimate bibi, qirita na 911 se gole ina vanua ni veiqaravi e voleka vei iko. E sega ni dua na veiwekani e tauyavutaki ena website qo se na kena vakayagataki. E sega ni dua na ka e tukuna se cakava na BioMedLib se o ira na kena tamata cakacaka, se o ira na vakaitavi ena website qo me baleta na itukutuku e tiko kina se na kena vakayagataki.']
['Disclaimer: dodonu ni lavelavetaki']
['Na Digital Millennium Copyright Act ni 1998, 17 U.S.C. § 512 (na DMCA) e vakarautaka na recourse me baleta na itaukei ni dodonu ni lavelavetaki era vakabauta ni iyaya e basika ena Initaneti e voroka na nodra dodonu ena ruku ni lawa ni dodonu ni lavelavetaki ni Amerika. ']
['Ke o vakabauta ni dua na ka e tabaki ena neimami website se na neimami veiqaravi e beci kina na nomu dodonu ni kena maroroi na itukutuku, o iko (se nomu mata) e rawa ni o vakauta mai e dua na notisi mo kerea me kau laivi se me tarovi na kena vakayagataki. ']
['Me vakau na itukutuku ena i-meli (raica na "Veitaratara" ena tabana e baleta na itikotiko ni imeli). ']
['Na DMCA e gadrevi kina na nomu itukutuku ni kena beitaki ni beci na dodonu ni lavelavetaki e oka kina na itukutuku oqo: (1) ivakamacala ni cakacaka ni taqomaki ni dodonu ni lavelavetaki e tukuni ni sa beci; (2) ivakamacala ni lewena e beitaki ni beci kei na itukutuku e veirauti me rawa kina ni da kunea na lewena; (3) itukutuku ni veitaratara me baleti iko, oka kina na nomu itikotiko, naba ni talevoni kei na itikotiko ni imeli; (4) e dua na itukutuku mai vei iko ni o vakabauta ena vakabauta vinaka ni lewena ena kena ivakarau e kudruvaka e sega ni vakadonui mai vua na itaukei ni dodonu ni lavelavetaki, se na kena mata, se ena cakacaka ni dua na lawa; ']
['(5) e dua na nomu ivakamacala, e sainitaki ena itotogi ni bubului lasu, ni dina na itukutuku e volai ena notisi, ni tu tale ga vei iko na dodonu mo valataka na dodonu ni kena taqomaki na ka e volai; ']
['E sega ni dodonu me dua na ka e caka ena kena vakayagataki na Internet.']
['Ke o sega ni vola na itukutuku kece qori, ena rawa ni berabera na kena qaravi na nomu kudru.']
['Veitaratara']
['Yalovinaka vakauta mai na imeli ena dua na taro se vakatutu.']
How deadly is alzheimer?
Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.
It is the most common cause of dementia, accounting for 60-80% of all cases.
The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.
The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.
According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.
In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.
It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.
As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.
Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.
While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.
Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Rauta na']
['Na BioMedLib e vakayagataka na kompiuta (machine-learning algorithms) me bulia na taro kei na kena isau.']
['Eda tekivu ena 35 na milioni na ivola vakavuniwai e tabaki ena PubMed/Medline, kei na tabana ni RefinedWeb.']
